We are pleased to announce that the G4PL – Genomics for Poland project has been awarded funding under the European Funds for a Modern Economy (FENG) 2021–2027 Programme, Action 2.4 "Research Infrastructure for a Modern Economy." The project is co-financed by the European Union.
Project Overview
- Programme: European Funds for a Modern Economy (FENG) 2021–2027
- Call: FENG.02.04-IP.04-001/25 – Research Infrastructure for a Modern Economy (network institution pathway)
- Project duration: 2026–2029
- Total project value: PLN 248,337,770.24
- EU funding: PLN 180,481,656.59
- Poznan University of Technology project value: PLN 7,555,179.05
- Funding awarded to Poznan University of Technology: PLN 6,570,469.72
- Project Leader at Poznan University of Technology: Dr. Aleksandra Świercz
A National Genomics Consortium
The project is being implemented by a consortium of leading Polish research institutions. The consortium is led by the Institute of Bioorganic Chemistry of the Polish Academy of Sciences (IBCH PAS), headed by Prof. Luiza Handschuh, and includes the Poznan Supercomputing and Networking Center (PSNC).
Other consortium members include:
- Poznan University of Technology
- Institute of Human Genetics, Polish Academy of Sciences
- Nencki Institute of Experimental Biology, Polish Academy of Sciences
- University of Warsaw
- Medical University of Białystok
- University of Łódź
- University of Gdańsk
- Jagiellonian University
- National Institute of Cardiology – Stefan Cardinal Wyszyński National Research Institute
- Maria Skłodowska-Curie National Research Institute of Oncology – Gliwice Branch
- Łukasiewicz Research Network – PORT Polish Center for Technology Development
The project also benefits from in-kind contributions provided by BCODERS S.A. and Analityk Genetyka Unrug Wójtowicz Sp. k.
Advancing Genomics Research in Poland
The primary objective of G4PL – Genomics for Poland is to establish a nationwide network of genomics laboratories that will conduct research and provide advanced genomic services for scientific institutions, healthcare providers, and industry. The project will support the development of:
- cutting-edge scientific research,
- personalized medicine,
- precision diagnostics,
- innovative therapies,
- targeted disease prevention.
Key Activities
As part of the project, the consortium will:
- establish state-of-the-art genomic research infrastructure,
- acquire high-throughput long-read DNA sequencing systems,
- implement optical genome mapping technologies,
- expand computational infrastructure for large-scale genomic data processing,
- develop innovative bioinformatics tools, including solutions based on artificial intelligence and quantum technologies,
- integrate and reanalyse existing genomic datasets,
- create a national genomic data repository.
The project also plans to sequence samples from 6,000–7,000 donors, including patients with rare diseases. Part of the generated data will constitute Poland's contribution to the Genome of Europe (GoE) initiative.
Who Will Benefit?
The project is designed to support:
- research institutions,
- biotechnology and medical companies,
- healthcare organisations,
- researchers and early-career scientists,
- patients benefiting from advanced genomic diagnostics.
By strengthening Poland's national genomics infrastructure, the project will increase access to state-of-the-art genetic research and diagnostics while enhancing the country's contribution to major European genomics initiatives.
Congratulations to Assoc. Prof. Aleksandra Świercz and all members of the consortium on securing this significant funding, which represents an important step toward advancing genomics research and precision medicine in Poland.
#FunduszeUE #FunduszeEuropejskie
Project Coordinator at PUT: assoc. prof.. Aleksandra Świercz
